|Year to Date: $492.87M|
Teva Pharmaceutical Industries Ltd.
Triggered by positive results from a Phase IIb trial of laquinimod in patients with multiple sclerosis (9/5)
Shire Pharmaceuticals Group plc (UK)
Triggered by Shire gaining approval in Germany to market Fosrenol for treating high phosphate levels in the blood (9/18)
AstraZeneca plc (UK)
Triggered upon initiation of a Phase II trial of AZD6244 (ARRY-142886), a selective MEK inhibitor, in advanced melanoma patients (9/14)
Triggered by progress in deal to generate a biocatalytic process for producing an inter- mediate for an undisclosed therapeutic compound (9/11)
Hana Biosciences Inc. (HNAB)
Triggered by Hana's initiation of Phase I trials of INX-0125 (sphingosomal vinorelbine) for treating advanced solid tumors (8/30)@
Amgen Inc. (AMGN)
Triggered by preclinical progress in effort to develop PDE10 inhibitors for treating certain neurological and psychiatric disorders (9/28)
Organon (the Netherlands)
Triggered by Pharmacopeia's delivery of two lead compound series, one for pain indications and one for obesity (9/19)
Triggered by Schering's initiation of a Phase I trial of a compound identified in their cancer- focused collaboration (9/11)
Serono SA (Switzerland; NYSE:SRA)
Triggered by Serono's initiation of a Phase I trial of R763 in patients with refractory solid tumors (9/19)
Milestone was reached under 2005 deal in which Wyeth is investigating Scolr's delivery platform for use in an OTC formulation; Wyeth also agreed to reimburse Scolr for certain R&D costs already incurred (9/26)
Triggered by initiation of a Phase II trial of TRU-015 for rheumatoid arthritis; the $8M payment includes reimbursement of prior manufacturing-related costs (9/27)
# Unless otherwise indicated, shares are traded on the Nasdaq exchange.
* Private company.
@News occurred in August but was not included in the previous chart.
Currency conversions are based on exchange rates at the time of the deal.
ND = Not disclosed.
AMEX = American Stock Exchange; NYSE = New York Stock Exchange; SSE = Stockholm Stock Exchange; TSX = Toronto Stock Exchange.